173 related articles for article (PubMed ID: 21981241)
1. Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model.
Gilson CR; Zimring JC
Transfusion; 2012 Apr; 52(4):849-59. PubMed ID: 21981241
[TBL] [Abstract][Full Text] [Related]
2. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation.
Semple JW; Speck ER; Milev YP; Blanchette V; Freedman J
Blood; 1995 Jul; 86(2):805-12. PubMed ID: 7606011
[TBL] [Abstract][Full Text] [Related]
3. CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.
Gilson CR; Patel SR; Zimring JC
Transfusion; 2012 Oct; 52(10):2209-19. PubMed ID: 22321003
[TBL] [Abstract][Full Text] [Related]
4. Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions.
Waterman HR; Kapp LM; Munday A; Odem-Davis K; Zimring JC
Transfusion; 2016 Jan; 56(1):91-100. PubMed ID: 26400622
[TBL] [Abstract][Full Text] [Related]
5. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.
Sayeh E; Aslam R; Speck ER; Le-Tien H; Lazarus AH; Freedman J; Semple JW
Transfusion; 2004 Nov; 44(11):1572-8. PubMed ID: 15504162
[TBL] [Abstract][Full Text] [Related]
6. Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets.
Muench MO; Heitman JW; Inglis H; Fomin ME; Marschner S; Goodrich RP; Norris PJ; Jackman RP
Transfusion; 2016 Jun; 56(6):1419-29. PubMed ID: 27028210
[TBL] [Abstract][Full Text] [Related]
7. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
[TBL] [Abstract][Full Text] [Related]
8. Role of class-II major histocompatibility complex (MHC)-antigen-positive donor leukocytes in transfusion-induced alloimmunization to donor class-I MHC antigens.
Kao KJ; del Rosario ML
Blood; 1998 Jul; 92(2):690-4. PubMed ID: 9657772
[TBL] [Abstract][Full Text] [Related]
9. Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens.
Bang KW; Speck ER; Blanchette VS; Freedman J; Semple JW
Blood; 2000 Mar; 95(5):1735-42. PubMed ID: 10688832
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells.
Aslam R; Speck ER; Kim M; Freedman J; Semple JW
Transfusion; 2008 Sep; 48(9):1778-86. PubMed ID: 18522705
[TBL] [Abstract][Full Text] [Related]
11. Alloimmunogenicity of an isolated MHC allele is affected by the context of MHC mismatch in a murine model.
Hudson KE; Wong ASL; Richards AL; Kapp LM; Zimring JC
Transfusion; 2019 Feb; 59(2):744-753. PubMed ID: 30681727
[TBL] [Abstract][Full Text] [Related]
12. Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase.
Bang A; Speck ER; Blanchette VS; Freedman J; Semple JW
Blood; 1996 Oct; 88(8):2959-66. PubMed ID: 8874192
[TBL] [Abstract][Full Text] [Related]
13. IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells.
Sayeh E; Sterling K; Speck E; Freedman J; Semple JW
Blood; 2004 Apr; 103(7):2705-9. PubMed ID: 14656873
[TBL] [Abstract][Full Text] [Related]
14. Two levels of help for B cell alloantibody production.
Steele DJ; Laufer TM; Smiley ST; Ando Y; Grusby MJ; Glimcher LH; Auchincloss H
J Exp Med; 1996 Feb; 183(2):699-703. PubMed ID: 8627185
[TBL] [Abstract][Full Text] [Related]
15. MHC II on transfused murine blood is not required for alloimmunization against MHC I.
Gilson CR; Cadwell CM; Smith NH; Hendrickson JE; Zimring JC
Vox Sang; 2010 Nov; 99(4):369-74. PubMed ID: 20546207
[TBL] [Abstract][Full Text] [Related]
16. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity.
Semple JW; Speck ER; Cosgrave D; Lazarus AH; Blanchette VS; Freedman J
Blood; 1999 Jan; 93(2):713-20. PubMed ID: 9885234
[TBL] [Abstract][Full Text] [Related]
17. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
Wong M; Narra R; Selim M; Zimmerman MA; Kim J; Padmanabhan A; Hong JC
J Surg Res; 2020 Nov; 255():99-105. PubMed ID: 32543385
[TBL] [Abstract][Full Text] [Related]
18. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.
Yu J; Heck S; Yazdanbakhsh K
Am J Hematol; 2007 Aug; 82(8):691-6. PubMed ID: 17492644
[TBL] [Abstract][Full Text] [Related]
19. Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice.
Couvidou A; Angénieux C; Ruch L; Mangin PH; Gachet C; Maître B
Blood Adv; 2023 Apr; 7(8):1356-1365. PubMed ID: 36490266
[TBL] [Abstract][Full Text] [Related]
20. The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells.
Hendrickson JE; Saakadze N; Cadwell CM; Upton JW; Mocarski ES; Hillyer CD; Zimring JC
Transfusion; 2009 Aug; 49(8):1678-84. PubMed ID: 19413728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
